Ethiopia is positioning its pharmaceutical industry for export markets after securing a higher international regulatory rating, while nearly halving its reliance on imported medicines by expanding domestic production, Prime Minister Abiy Ahmed (PhD) said.
Addressing parliament on Tuesday, Abiy said Ethiopia has achieved Maturity Level 3 under the World Health Organization's global benchmarking system for national medicines regulatory authorities, a milestone he said strengthens the international credibility of medicines produced in the country.
"The next target is Maturity Level 4," the prime minister said, adding that the latest recognition would open opportunities for Ethiopian-made medicines to gain acceptance in global export markets.
The regulatory upgrade comes as Ethiopia increases local pharmaceutical manufacturing. Abiy said domestic producers now meet between 44 percent and 45 percent of the country's medicine demand, up from about 4 percent in previous years, reducing dependence on imported pharmaceuticals.
The government allocated 70 billion birr to medicine procurement during the fiscal year, while continuing to support local manufacturers through investments in pharmaceutical production and research institutions, including the Armauer Hansen Research Institute, to strengthen vaccine research, production support and regulatory capacity.
Abiy said more than 60 billion birr was also spent on procuring medical equipment, enabling health facilities to acquire modern technologies as part of a broader effort to improve healthcare services.
He said expanding access to healthcare requires building additional facilities rather than relying solely on existing referral hospitals, given Ethiopia's growing population. Several health institutions have recently opened in Addis Ababa, with more expected to begin operations in the coming months.
As part of that expansion, St. Paul's Hospital Millennium Medical College is being upgraded to accommodate an additional 1,000 beds. However, Abiy acknowledged that demand for healthcare services and accumulated treatment backlogs remain significant, requiring sustained investment.
While describing recent progress as encouraging, the prime minister said Ethiopia aims to establish internationally competitive healthcare institutions over the next five years.
Abiy also highlighted public health interventions undertaken during the fiscal year. Nearly 14 million mosquito nets were distributed free of charge to prevent malaria, while indoor residual spraying was carried out in almost three million households.
He added that Ethiopia has launched malaria vaccination in 58 districts for the first time in the country's history.
The prime minister said the government would continue investing in health, education and other social sectors to improve service delivery and support long-term development.
